Basic information
Biomarker: PCNA
Histology type: endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Nagasaki
Followed up time :
Subgroup 1 name : positive
Subgroup 1 number: 21
Subgroup 2 name: negative
Subgroup 2 number: 28
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
84 | EC | 49 | hyperplasia | 20 | normal endometrium | 15 |
Sample information
Conclusion: In conclusion, PCNA protein are related to the proliferation of endometrial carcinoma. So they can be useful factor in making the prognosis.
Sample type : tissue
Sample method: immuno-histochemical staining
Disease information
Related information
Funtion Uniprot: Auxiliary protein of DNA polymerase delta and epsilon, is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand (PubMed:35585232). Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways (PubMed:24939902). Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: Monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion (PubMed:24695737).
UniProt ID: P12004
UniProt Link: https://www.uniprot.org/uniprotkb/P12004/entry
Biological function from UniProt: #DNA damage #DNA repair #DNA replication #Host-virus interaction
Molecular function from UniProt:
Subcellular UniProt: #Nucleus
Alternative name from UniProt:
Miscellaneous: Antibodies against PCNA are present in sera from patients with systemic lupus erythematosus.
Recommended name: Proliferating cell nuclear antigen
Gene name from HGNC: PCNA
HPA class: Cancer-related genes Disease related genes Human disease related genes Plasma proteins
AlphaFold DB: P12004
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P12004
HPA link: https://www.proteinatlas.org/ENSG00000132646-PCNA
Tissue specificity RNA from HPA: Tissue enhanced (bone marrow)
Tissue expression from HPA: Nuclear expression mainly in proliferative cells.
Single cell type specificity Non-specific - Cell cycle regulation (mainly)
Immune cell specificity: Low immune cell specificity
Subcellular summary HPA Located in Nucleoplasm (Single cell variability, CCD Transcript)
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), cervical cancer (favorable) and liver cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000132646-PCNA/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000132646-PCNA/pathology/endometrial+cancer
Phenotype ID: 615919
Disease: Ataxia-telangiectasia-like disorder 2 (ATLD2)
Note1: The disease is caused by variants affecting the gene represented in this entry
OMIM: 176740
OMIM link1: https://www.omim.org/entry/615919
OMIM link2: https://www.omim.org/entry/176740
HGNC ID: HGNC:8729
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:8729